Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$754 Hold
231
﹤0.01% 1101
2026
Q1
$2.04K Sell
231
-6
-3% -$63 ﹤0.01% 1039
2025
Q4
$2.82K Hold
237
﹤0.01% 1020
2025
Q3
$3.35K Hold
237
﹤0.01% 977
2025
Q2
$2.3K Sell
237
-9
-4% -$101 ﹤0.01% 923
2025
Q1
$3.14K Hold
246
﹤0.01% 937
2024
Q4
$5.08K Hold
246
﹤0.01% 900
2024
Q3
$3.47K Sell
246
-3
-1% -$44 ﹤0.01% 924
2024
Q2
$3.11K Sell
249
-36
-13% -$437 ﹤0.01% 915
2024
Q1
$3.78K Sell
285
-400
-58% -$6.2K ﹤0.01% 881
2023
Q4
$13K Buy
685
+160
+30% +$2.63K ﹤0.01% 792
2023
Q3
$7.9K Sell
525
-390
-43% -$7.31K ﹤0.01% 842
2023
Q2
$19.8K Sell
915
-328
-26% -$8.94K ﹤0.01% 729
2023
Q1
$35K Sell
1,243
-1,144
-48% -$32.5K ﹤0.01% 636
2022
Q4
$60.4K Sell
2,387
-5,252
-69% -$160K ﹤0.01% 529
2022
Q3
$220K Sell
7,639
-2,023
-21% -$59.9K 0.01% 350
2022
Q2
$245K Buy
+9,662
New +$278K 0.01% 339

Other funds holding EMBC

HM Payson & Co's EMBC Position: Q2 2026 in Review

HM Payson & Co held its Embecta (EMBC) position steady in Q2 2026 at 231 shares worth $754. The position accounts for ﹤0.01% of the portfolio, ranked #1101.

HM Payson & Co first reported a position in EMBC in Q2 2022 and has held it in 17 quarters since. The position peaked at $245K in Q2 2022. 321 funds tracked by Wall St. Rank hold EMBC as of Q2 2026.

  • HM Payson & Co held 231 shares of Embecta worth $754 as of Q2 2026.
  • HM Payson & Co left its Embecta share count unchanged in Q2 2026.
  • Embecta made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #1101 holding.
  • HM Payson & Co first reported a position in Embecta in Q2 2022 and has held it in 17 quarters since.
  • HM Payson & Co's Embecta position peaked at $245K in Q2 2022.
  • 321 funds tracked by Wall St. Rank held Embecta as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.